A recent meta-analysis including 18,715 patients treated with anti-PD-1 or anti-PD-L1 observed an incidence of pneumonitis of 2.8% (95% CI, 2.4–3.2%) [18]. This evidence concerns the gene CD274 and pneumonitis.